Clinical Trials Sponsored by Decathlon SE

Total 248 results

BioNTech SE
Pfizer

Completed

A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults

COVID-19 | SARS-CoV-2 Infection

United States
BioNTech SE
Pfizer

Completed

A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants

COVID-19 | SARS-CoV-2 Infection

United States
Axon Neuroscience SE

Unknown

A 24-month Phase 1 Pilot Study of AADvac1 in Patients With Non Fluent Primary Progressive Aphasia (AIDA)

Primary Progressive Nonfluent Aphasia

Germany
Axon Neuroscience SE

Completed

Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease

Alzheimer Disease

Austria
Genmab
BioNTech SE

Recruiting

Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy

Malignant Solid Tumor

Spain
BioNTech SE
Genmab

Recruiting

Safety and Preliminary Efficacy of BNT314 With or Without an Immune Checkpoint Inhibitor in Cancer Patients With Malignant Solid Tumors

Advanced Malignant Solid Tumor

United States, United Kingdom
Genmab
BioNTech SE

Active, not recruiting

GEN1046 Safety Trial in Patients With Malignant Solid Tumors

Cervical Cancer | Squamous Cell Carcinoma of the Head and Neck | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Solid Tumors | Endometrial Carcinoma | Urothelial Carcinoma

United States, Spain, Israel, Czechia, Georgia, Italy, Poland, Turkey, Hungary, Ukraine
Genmab
BioNTech SE

Withdrawn

GEN1046 in Combination With Anticancer Agents for the Treatment of Advanced Endometrial Cancer

Advanced Endometrial Cancer

Korea, Republic of, Spain, Belgium, United States, Denmark, Italy
BioNTech SE
Pfizer

Withdrawn

A Study to Learn About Bivalent COVID-19 RNA Vaccine Candidate(s) in Healthy Infants and Children

COVID-19
BioNTech SE
Pfizer

Active, not recruiting

A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals

COVID-19 | SARS-CoV-2 Infection

United States
BioNTech SE
Pfizer

Completed

Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals

COVID-19 | SARS-CoV-2 Infection

United States, Germany, Turkey, South Africa, Argentina, Brazil
Genmab
BioNTech SE

Recruiting

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

Malignant Solid Tumor

Japan
BioNTech SE
Pfizer

Recruiting

A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

COVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 | SARS-CoV-2 Virus

United States, South Africa, Brazil, Puerto Rico
Genmab
BioNTech SE

Recruiting

A Safety and Antitumor Activity Trial of Immunoradiotherapy Combinations as a Treatment Option for Subjects With Metastatic Solid Tumors

Non-CNS Tumor

France
Genmab
BioNTech SE

Recruiting

GEN1042 Safety Trial and Anti-tumor Activity in Subjects With Malignant Solid Tumors

Melanoma | Malignant Solid Tumor | Non Small Cell Lung Cancer (NSCLC) | Pancreatic Ductal Adenocarcinoma (PDAC) | Head and Neck Squamous Cell Carcinoma (HNSCC) | Colorectal Cancer (CRC)

United States, Taiwan, Spain, Israel, Korea, Republic of, France, Italy, Denmark, Germany, United Kingdom, Georgia, Moldova, Republic of
Genmab
BioNTech SE

Terminated

A Study to Evaluate Safety, Tolerability, and Preliminary Effect of the GEN1053 Antibody on Malignant Solid Tumors as Monotherapy

Solid Tumor, Adult

Spain, United States
Genmab
BioNTech SE

Active, not recruiting

Study of Safety and Antitumor Activity of GEN1056 in Participants With Advanced Solid Tumors

Solid Tumor, Adult

Spain, Georgia, Moldova, Republic of
Genmab
BioNTech SE

Active, not recruiting

GEN1046 Safety and PK in Subjects With Advanced Solid Malignancies

Solid Tumor

Japan
BioNTech SE
Pfizer

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza

COVID-19 | Influenza, Human

United States
BioNTech SE
Pfizer

Completed

A Study to Learn About New COVID-19 RNA Vaccine Candidates in COVID-19 Vaccine-Experienced Healthy Individuals

COVID-19 | SARS-CoV-2 Infection

United States
BioNTech SE
Pfizer

Completed

Study to Evaluate Safety, Tolerability & Immunogenicity of BNT162b2 in Immunocompromised Participants ≥2 Years

SARS-CoV-2 Infection, COVID19

United States, Brazil, Germany, Mexico
BioNTech SE
Pfizer

Completed

Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age

COVID-19 | SARS-CoV-2 Infection

Australia, New Zealand
Axon Neuroscience SE

Completed

24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease (ADAMANT)

Alzheimer's Disease

Poland, Austria, Czechia, Germany, Romania, Slovakia, Slovenia, Sweden
Axon Neuroscience SE

Completed

18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease (FUNDAMANT)

Alzheimer's Disease

Austria
DualityBio Inc.
BioNTech SE

Recruiting

A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)

Metastatic Breast Cancer

United States, China, France, Australia
Biotronik SE & Co. KG

Recruiting

BIOSTREAM.HF HeartInsight

Heart Failure

France, Czechia, Portugal, Latvia, Hungary
DualityBio Inc.
BioNTech SE

Recruiting

First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors

Advanced Solid Tumor

United States, China, Puerto Rico
Biotronik SE & Co. KG

Active, not recruiting

Post Market Clinical Follow-up Study for the Pamira ICD Lead Family

Heart Failure | Tachyarrhythmia

Hungary, Latvia, Israel, Belgium, Germany, Australia, Austria, Slovakia
Biotronik SE & Co. KG

Active, not recruiting

SD01 Registry (SD01 ICD Lead) (SD01 Registry)

Heart Failure | Ventricular Fibrillation | Ventricular Tachycardia

Germany
Biotronik SE & Co. KG

Completed

Master Study of the BIOMONITOR III and Incision and Insertion Tool (FIT OneStep)

Syncope | Atrial Fibrillation (AF) | Cryptogenic Stroke | Tachyarrhythmia

Spain, Australia, Germany, Switzerland, Austria, Denmark
Biotronik SE & Co. KG

Completed

BIO|CONCEPT.BIOMONITOR III

Atrial Fibrillation | Syncope | Tachyarrhythmia

Australia
Biotronik SE & Co. KG

Completed

A Prospective Pilot Study (BIO|SELECT Pilot)

Heart Failure

Japan
Biotronik SE & Co. KG

Terminated

Preventive aBlation of vEntricular tachycaRdia in Patients With myocardiaL INfarction (BERLIN VT)

Ventricular Tachycardia

Germany
Biotronik SE & Co. KG

Completed

BIO|MASTER.Ilivia Family / Plexa

Heart Failure | Tachyarrhythmia

Denmark, France, Germany, Spain, Switzerland, Israel, Latvia, Australia, Singapore, Austria
Biotronik SE & Co. KG

Terminated

Assessment of Pacing Stimulus Conduction and Latency Measurements in CRT-D Patients (BIO|PULSE)

Heart Failure

Germany, Czechia, Netherlands
Biotronik SE & Co. KG

Completed

Management and Detection of Atrial Tachyarrhythmias in Patients Implanted With BIOTRONIK DX Systems (MATRIX)

Heart Failure | Atrial Fibrillation | Tachycardia | Thromboembolic Events | ICD Therapy

Germany
Biotronik SE & Co. KG

Terminated

Follow-up of Patients With Implantable Cardioverter Defibrillators by Home Monitoring (ANVITE) (ANVITE)

Ventricular Tachyarrhythmia | Cardiac Pacing | Electric Countershock

Germany
Biotronik SE & Co. KG

Completed

Eluna Family / Sentus BP Master Study

Heart Failure | Bradycardia

Denmark, Hong Kong, Austria, Germany, Belgium
Biotronik SE & Co. KG

Completed

Monitoring of Hemodynamics in Heart Failure Patients by Intracardiac Impedance Measurement (BIODetectHFII)

Heart Failure

Netherlands, Switzerland, Germany, Denmark, Italy
Biotronik SE & Co. KG

Withdrawn

Clinical Registry on Sudden Death Primary Prevention at Latin America (ESCAPE-ICD)

Myocardial Infarction | Sudden Death

Argentina
Biotronik SE & Co. KG

Completed

Setrox JS Master Study

Cardiac Disease

Czech Republic
Biotronik SE & Co. KG

Completed

Lumax DX / Linox DX Evaluation

Cardiac Disease

Germany
Biotronik SE & Co. KG

Completed

Psychosomatic Effects of Implantable Cardioverter Defibrillator With Home Monitoring Function (QUANTUM)

Quality of Life | Arrhythmia

Germany, Austria, Switzerland
Biotronik SE & Co. KG

Completed

SIELLO Pilot Study for Comparison of Steroid Versus Non-Steroid Pacing Leads

Arrhythmias, Cardiac

Hungary
Biotronik SE & Co. KG

Completed

Master Study for the Investigation of Safety and Efficacy of the EVIA Pacemaker

Pacemaker Indication

France
Biotronik SE & Co. KG

Completed

Benefits of Implantable Cardioverter Defibrillator Follow-up Using Remote Monitoring (ECOST)

Ventricular Fibrillation | Tachycardia, Ventricular | Implantable Cardioverter-Defibrillators

France
Biotronik SE & Co. KG

Completed

Home Monitoring in Cardiac Resynchronisation Therapy (HomeCARE)

Heart Failure, Congestive

Germany, Israel, Netherlands, Czech Republic, United Kingdom, France, Austria, Italy, Latvia, Spain
BioNTech SE
DualityBio Inc.

Not yet recruiting

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

Endometrial Cancer
DualityBio Inc.
BioNTech SE

Recruiting

A Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast Cancer

HER2-positive Breast Cancer

China
Biotronik SE & Co. KG

Recruiting

Post Market Clinical Follow-up Study for the Amvia/Solvia Pacemaker Family

Heart Failure | Bradycardia

Austria, Germany

Clinical Trials Sponsored by Decathlon SE

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations